Magnera launches a PFAS-free fluid repellency solution for nonwoven textiles, addressing regulatory demands and environmental concerns.
Quiver AI Summary
Magnera, a prominent advanced material solutions provider based in Charlotte, NC, has launched a new innovative product for nonwoven textiles that offers fluid repellency without using per- and polyfluoroalkyl substances (PFAS). This development comes in response to increasing global regulatory measures aimed at limiting PFAS due to environmental and health concerns. The company's Chief Innovation and Marketing Officer, Paul Harmon, emphasized that the new solution complies with strict industry standards, enhancing protection, comfort, and sustainability for healthcare textiles like surgical gowns and drapes. As various regulations come into effect, and demand for PFAS alternatives rises, Magnera's product positions itself as a timely, responsible solution for industries transitioning away from harmful substances.
Potential Positives
- Magnera has launched a next-generation solution for nonwoven textiles that provides fluid repellency without the use of PFAS, addressing growing environmental and health concerns.
- The innovation positions Magnera favorably in the market as global regulatory bodies increasingly restrict PFAS use, creating strong demand for alternative materials.
- Magnera’s solution aligns with industry standards for protection, comfort, and compliance, enhancing their credibility and attractiveness to healthcare professionals and other industries.
- The company emphasizes its commitment to environmental responsibility and sustainability, which could improve brand perception and customer loyalty.
Potential Negatives
- Potential backlash from stakeholders concerned about the rapid shift away from PFAS due to previous reliance on these substances in their products.
- Increased scrutiny from regulators and consumers regarding the new product's efficacy compared to traditional PFAS-based solutions.
- Dependence on meeting evolving regulatory standards may strain the company's resources and affect pricing strategy amidst a shifting market.
FAQ
What is Magnera's new innovation for nonwoven textiles?
Magnera's latest solution offers fluid repellency for nonwoven textiles without using PFAS, catering to healthcare and other industries.
Why is Magnera's solution significant for healthcare?
This solution provides necessary protection and comfort while aligning with global trends to reduce PFAS in textile manufacturing.
How does Magnera's product meet regulatory standards?
The innovation complies with stringent industry standards, addressing growing concerns about PFAS regulations in healthcare textiles.
What industries can benefit from Magnera's advanced textile solutions?
Healthcare, protective apparel, and various other industries seeking environmentally friendly alternatives can benefit from Magnera's products.
How does Magnera ensure environmental responsibility?
By eliminating intentionally added PFAS, Magnera's solution promotes sustainability and reduces potential environmental pollutants.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$MAGN Insider Trading Activity
$MAGN insiders have traded $MAGN stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $MAGN stock by insiders over the last 6 months:
- MICHAEL S CURLESS purchased 10,000 shares for an estimated $122,939
- SAMANTHA J. MARNICK purchased 4,000 shares for an estimated $49,510
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MAGN Revenue
$MAGN had revenues of $839M in Q3 2025. This is an increase of 152.63% from the same period in the prior year.
You can track MAGN financials on Quiver Quantitative's MAGN stock page.
$MAGN Hedge Fund Activity
We have seen 68 institutional investors add shares of $MAGN stock to their portfolio, and 127 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FULLER & THALER ASSET MANAGEMENT, INC. removed 1,317,215 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $15,437,759
- IRENIC CAPITAL MANAGEMENT LP removed 1,210,829 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $14,190,915
- SCOPIA CAPITAL MANAGEMENT LP removed 1,010,794 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $11,846,505
- LOOMIS SAYLES & CO L P removed 604,734 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $7,305,186
- MADISON AVENUE PARTNERS, LP removed 511,724 shares (-15.3%) from their portfolio in Q3 2025, for an estimated $5,997,405
- MILLENNIUM MANAGEMENT LLC removed 511,171 shares (-71.0%) from their portfolio in Q3 2025, for an estimated $5,990,924
- UBS GROUP AG removed 410,121 shares (-37.3%) from their portfolio in Q3 2025, for an estimated $4,806,618
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MAGN Analyst Ratings
Wall Street analysts have issued reports on $MAGN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 11/24/2025
To track analyst ratings and price targets for $MAGN, check out Quiver Quantitative's $MAGN forecast page.
Full Release
CHARLOTTE, N.C., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Magnera, a leading supplier of advanced material solutions, today announced the launch of its next-generation solution for nonwoven textiles. Magnera’s proprietary innovation delivers fluid repellency needed by healthcare professionals and other industries without the use of per- and polyfluoroalkyl substances (PFAS).
PFAS have been widely used for decades in medical gowns, drapes, and other protective textiles due to their durability and resistance to water, oil, and stains. However, evidence of PFAS persistence in the environment and possible associated health risks has prompted global regulatory action and growing demand for alternatives.
Paul Harmon, Chief Innovation and Marketing Officer at Magnera, said: “Our new solution meets the industry’s stringent standards for protection, comfort, and compliance in articles such as surgical gowns or drapes, while reducing potential pollutants.”
Addressing a Global Challenge
Regulatory bodies worldwide are moving to restrict or reduce PFAS inclusion in manufacturing:
- The European Union: The European Chemicals Agency (ECHA) has published an updated proposal to restrict PFAS under the REACH regulation. The plan proposes phased bans and possible time-limited exemptions for essential uses, with final opinions expected in 2026 before requested implementation by the European Commission. (European Chemicals Agency, 2025).
- United States: Several states—including California, Maine, and Minnesota—have enacted laws banning the addition of PFAS in various consumer products, with some compliance deadlines starting in 2025. These bans target categories such as food packaging, textiles, cookware, and juvenile products. (Safer States, 2024).
As global manufacturers step away from solutions including PFAS, supply shortages and rising costs are accelerating the need for alternatives. Magnera’s innovation delivers a timely, future-ready solution for healthcare providers and other industries navigating this shift.
A Safer, Sustainable Alternative
Magnera’s Groundbreaking Solution Offers:
- High-performance fluid repellency without intentionally added PFAS
- Comfort and breathability for protective textiles
- Alignment with evolving global regulatory trends
- Increased Environmental responsibility
To learn more about Magnera’s solution, contact [email protected] or visit https://magnera.com/contact/
About Magnera
Magnera Corporation (NYSE: MAGN) serves 1,000+ customers worldwide, offering a wide range of material solutions, including components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products serving the food and beverage industry. Operating across 45 production facilities, Magnera is supported by over 8,500 global employees.
Magnera’s purpose is to better the world with new possibilities made real. For more than 160 years, the company has delivered the material solutions its partners need to thrive. Through economic upheaval, global pandemics, and changing end-user needs, we have consistently found ways to solve problems and exceed expectations. The distinct scale and comprehensive portfolio of products bring customers more materials and choices. Magnera builds personal partnerships that withstand an ever-changing world.
Visit magnera.com for more information and follow @MagneraCorporation on social platforms.
Forward-Looking Statements
Information included or incorporated by reference in Magnera Corporation’s filings with the U.S. Securities and Exchange Commission (the “SEC”) and press releases or other public statements contain or may contain “forward-looking” statements with the meaning of the federal securities laws and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such “forward-looking” statements include, but are not limited to, statements with respect to our financial condition, results of operations and business, our expectations or beliefs concerning future events, statements about future financial and operating results, the company’s plans, objectives, expectations and intentions and other statements that are not historical facts. These statements contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “projects,” “outlook,” “anticipates,” or “looking forward” or similar expressions that relate to our strategy, plans, intentions or expectations. All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are based upon the current beliefs and expectations of the management of Magnera and are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected. These risks and other risk factors are detailed from time to time in Magnera’s reports filed with the SEC, including annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, including our Form 8-K/A filed on January 31, 2025, and other documents filed with the SEC. These risk factors may not contain all of the material factors that are important to you. New factors may emerge from time to time and it is not possible to either predict new factors or assess the potential effect of any such new factors. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are based upon information available as of the date hereof. All forward-looking statements are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events, or otherwise, except as otherwise required by law.
References
1: European Chemicals Agency. (2025, August 20).
ECHA publishes updated PFAS restriction proposal
[Press release]. ECHA.
https://echa.europa.eu/-/echa-publishes-updated-pfas-restriction-proposal
2: Safer States. (2024, July).
State Action on PFAS in Consumer Products
. Safer States.
https://www.saferstates.org/resource/state-action-on-pfas/
Investor Contact:
Robert Weilminster
[email protected]
Media Contact:
Kylee Agabashian
[email protected]